41 employees
Biomarker discovery organization accelerating drug development through rapid, large-scale small molecule biomarker profiling.
2020
$9.2M
from 2 investors over 2 rounds
Sapient raised $9.2M on July 11, 2022
Investors: Bill & Melinda Gates Foundation
Sapient raised $4.6M on September 1, 2020